Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCash Due from BankCommon EquityFed Funds SoldGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLoans - GrossLoans - Loss AllowanceLoans - NetLong-Term InvestmentsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Receivables - AccuredRetained EarningsSecuritiesSecurities - Mortgage Backed SecuritiesSecurities - TradableShareholder's EquityShort-term InvestmentsTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MetroCity Bankshares (MCBS) Fed Funds Sold (2018 - 2025)

MetroCity Bankshares (MCBS) has disclosed Fed Funds Sold for 8 consecutive years, with $22.7 million as the latest value for Q3 2025.

  • On a quarterly basis, Fed Funds Sold rose 82.1% to $22.7 million in Q3 2025 year-over-year; TTM through Sep 2025 was $22.7 million, a 82.1% increase, with the full-year FY2024 number at $13.5 million, down 24.15% from a year prior.
  • Fed Funds Sold was $22.7 million for Q3 2025 at MetroCity Bankshares, roughly flat from $22.7 million in the prior quarter.
  • In the past five years, Fed Funds Sold ranged from a high of $22.7 million in Q1 2025 to a low of $3.0 million in Q3 2023.
  • A 5-year average of $14.3 million and a median of $15.6 million in 2022 define the central range for Fed Funds Sold.
  • Peak YoY movement for Fed Funds Sold: plummeted 81.17% in 2023, then skyrocketed 322.3% in 2024.
  • MetroCity Bankshares' Fed Funds Sold stood at $8.8 million in 2021, then soared by 98.38% to $17.5 million in 2022, then increased by 2.02% to $17.8 million in 2023, then decreased by 24.15% to $13.5 million in 2024, then surged by 67.64% to $22.7 million in 2025.
  • Per Business Quant, the three most recent readings for MCBS's Fed Funds Sold are $22.7 million (Q3 2025), $22.7 million (Q2 2025), and $22.7 million (Q1 2025).